{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:28:35Z","timestamp":1648765715433},"reference-count":24,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5582\/bst.8.38","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T23:00:32Z","timestamp":1395097232000},"page":"38-44","source":"Crossref","is-referenced-by-count":3,"title":["The supercritical CO2 extract from the skin of Bufo bufo gargarizans Cantor blocks hepatitis B virus antigen secretion in HepG2.2.15 cells"],"prefix":"10.5582","volume":"8","author":[{"given":"Xiaoyan","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kokudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingzhi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bader T, Korba B. Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors <i>in vitro<\/i>. Antiviral Res. 2010; 86:241-245.","DOI":"10.1016\/j.antiviral.2010.02.325"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang CY, Zhong YS, Guo LP. Strategies to prevent hepatitis B virus infection in China: Immunization, screening, and standard medical practices. Biosci Trends. 2013; 7:7-12.","DOI":"10.5582\/bst.2013.v7.1.7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Song PP, Feng XB, Zhang KM, Song TQ, Ma KS, Kokudo N, Dong JH, Yao LN, Tang W. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: Promoting the early detection of hepatocellular carcinoma in China. Biosci Trends. 2013; 7:1-6.","DOI":"10.5582\/bst.2013.v7.1.1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Feld J, Locarnini S. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges. J Clin Virol. 2002; 25:267-283.","DOI":"10.1016\/S1386-6532(02)00107-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Perrillo RP. Current treatment of chronic hepatitis B: benefits and limitations. Semin Liver Dis. 2005; 25 (Suppl.):20-28.","DOI":"10.1055\/s-2005-915647"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review. Hepatology. 2010; 51:690-698.","DOI":"10.1002\/hep.23384"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chen KK, Kovar\u00edkov\u00e1 A. Pharmacology and toxicology of toad venom. J Pharm Sci. 1967; 56:1535-1541.","DOI":"10.1002\/jps.2600561202"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zhang J, Sun Y, Liu JH, Yu BY, Xu Q. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure\u2013activity relationship (SAR). Bioorg Med Chem Lett. 2007; 17:6062-6065.","DOI":"10.1016\/j.bmcl.2007.09.065"},{"key":"9","unstructured":"9. Qi FH, Li AY, Lv H, Zhao L, Li JJ, Gao B, Tang W. Apoptosis-inducing effect of cinobufacini, <i>Bufo bufo gargarizans<\/i> Cantor skin extract, on human hepatoma cell line BEL-7402. Drug Discov Ther. 2008; 2:339-343."},{"key":"10","unstructured":"10. Dai LP, Gao HM, Wang ZM, Wang WH. Isolation and structure identification of chemical constituents from the skin of <i>Bufo bufo gargarizans<\/i>. Yao Xue Xue Bao. 2007; 42:858-861."},{"key":"11","unstructured":"11. Lan YN. Long-term efficacy of cinobufacini for treatment of chronic hepatitis B. Chin J Clin Hepatol. 2002; 18:374-375."},{"key":"12","unstructured":"12. Cui XY, Wang YL, Kokudo N, Fang DZ, Tang W. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010; 4:39-47."},{"key":"13","unstructured":"13. Wang WM, Li RH. Clinical observation of cinobufacini injection on 118 patients with chronic hepatitis B. Mod J Integr Tradit Chin West Med. 2001; 10:1632-1633."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cui XY, Inagaki Y, Xu HL, Wang DL, Qi FH, Kokudo N, Fang DZ, Tang W. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells. Biol Pharm Bull. 2010; 33:1728-1732.","DOI":"10.1248\/bpb.33.1728"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lenucci MS, Caccioppola A, Durante M, Serrone L, Leonardo R, Piroa G, Dalessandro G. Optimisation of biological and physical parameters for lycopene supercritical CO2 extraction from ordinary and high-pigment tomato cultivars. J Sci Food Agric. 2010; 90:1709-1718.","DOI":"10.1002\/jsfa.4006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Marongiua B, Pirasa A, Porceddaa S, Falconierib D, Gon\u00e7alves MJ, Salgueiroc L, Maxiad A, Lai R. Extraction, separation and isolation of volatiles from Vitex agnus-castus L. (Verbenaceae) wild species of Sardinia, Italy, by supercritical CO2. Nat Prod Res. 2010; 24:569\u2013579.","DOI":"10.1080\/14786410902899915"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA. 1987; 84:1005-1009.","DOI":"10.1073\/pnas.84.4.1005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kamisango K, Kamogawa C, Sumi M, Goto S, Hirao A, Gonzales F, Yasuda K, Iino S. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol. 1999; 37:310-314.","DOI":"10.1128\/JCM.37.2.310-314.1999"},{"key":"19","unstructured":"19. Ji GS. Effect of lamivudine alone or in combination with cinobufacini on serum markers in patients with hepatitis B. Chin J Integrated Trad and Western Med on Liver Diseases. 2005; 15:53-54."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wang DL, Qi FH, Tang W, Wang FS. Chemical constituents and bioactivities of the skin of <i>Bufo bufo gargarizans<\/i> Cantor. Chem Biodivers. 2011; 8:559-567.","DOI":"10.1002\/cbdv.201000283"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wang S, Li J, Huang H, Gao W, Zhuang C, Li B, Zhou P, Kong D. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biol Pharm Bull. 2009; 32:132-135.","DOI":"10.1248\/bpb.32.132"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhou Z, Zhang Y, Ding XR, Chen SH, Yang J, Wang XJ, Jia GL, Chen HS, Bo XC, Wang SQ. Protocatechuic aldehyde inhibits hepatitis B virus replication both <i>in vitro<\/i> and <i>in vivo<\/i>. Antiviral Res. 2007; 74:59-64.","DOI":"10.1016\/j.antiviral.2006.12.005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rowe HM, Kapopoulou A, Corsinotti A, Fasching L, Macfarlan TS, Tarabay Y, Viville S, Jakobsson J, Pfaff SL, Trono D. TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells. Genome Res. 2013; 23:452-461.","DOI":"10.1101\/gr.147678.112"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ito K, Kim KH, Lok AS, Tong S. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol. 2009; 83:3507-3517.","DOI":"10.1128\/JVI.02348-08"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:30:22Z","timestamp":1621531822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/8\/1\/8_38\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.8.38","relation":{},"ISSN":["1881-7815"],"issn-type":[{"value":"1881-7815","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}